Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies

by Popat S.
Published 2023

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Targete...

by Popat S.
Published 2023

The effect of resting morphological lip shape during lip movement: A three-dimensional motion analysis study

by Nasir, Siti Hajjar, Popat, Hashmat, Richmond, Stephen
Published 2020

Bursting the bubble on bacterial biofilms : a flow cell methodology

by Crusz, Shanika A., Diggle, Stephen P., Popat, Roman, Rybtke, Morten Theil, Cámara, Miguel, Givskov, Michael, Tolker-Nielsen, Tim, Williams, Paul
Published 2013

Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease (BMC Cancer, (2020), 20, 1, (1210), 10.1186/s12885-020-07662-y)

by Collins, DC, Sundar, R, Constantinidou, A, Dolling, D, Yap, TA, Popat, S, O’Brien, ME, Banerji, U, de Bono, JS, Lopez, JS, Tunariu, N, Minchom, A
Published 2021

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

by Collins, DC, Sundar, R, Constantidinou, A, Dolling, D, Yap, TA, Popat, S, O’Brien, ME, Banerji, U, de Bono, JS, Lopez, JS, Tunariu, N, Minchom, A
Published 2021

Strengthening reporting of neonatal trials

by Webbe, James, Ami, Baba, Butcher, Nancy J., Rodrigues, Craig, Stallwood, Emma, Goren, Katherine, Monsour, Andrea, S. M. Chang, Alvin, Trivedi, Amit, Manley, Brett J., McCall, Emma, Bogossian, Fiona, Namba, Fumihiko, Schmölzer, Georg M, Popat, Himanshu, Nguyen, Kim An, Doyle, Lex W., Jardine, Luke, Rysavy, Matthew A., Konstantinidis, Menelaos, Muhd Helmi, Muhd Alwi, Lai, Nai Ming, Hay, Susanne, Onland, Wes, Choo, Yao Mun, Gale, Chris, Soll, Roger F, Offringa, Martin
Published 2023

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 stud...

by Passaro, A., Wang, J., Wang, Y., Lee, S. -H., Melosky, B., Shih, J. -Y., Wang, J., Azuma, K., Juan-Vidal, O., Cobo, M., Felip, E., Girard, N., Cortot, A. B., Califano, R., Cappuzzo, F., Owen, S., Popat, S., Tan, J. -l., Salinas, J., Tomasini, P., Gentzler, R. D., William, W. N., Reckamp, K. L., Takahashi, T., Ganguly, S., Kowalski, D. M., Bearz, A., MacKean, M., Barala, P., Bourla, A. B., Girvin, A., Greger, J., Millington, D., Withelder, M., Xie, J., Sun, T., Shah, S., Diorio, B., Knoblauch, R. E., Bauml, J. M., Campelo, R. G., Cho, B. C., Investigators, MARIPOSA-2
Published 2024